Investing.com - OKYO Pharma Ltd (NASDAQ: OKYO) reported fourth quarter EPS of $-0.10, in line with the analyst estimate of $-0.10. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
OKYO Pharma Ltd's stock price closed at $1.40. It is down -15.92% in the last 3 months and down -38.05% in the last 12 months.
OKYO Pharma Ltd saw positive EPS revisions and negative EPS revisions in the last 90 days. See OKYO Pharma Ltd's stock price’s past reactions to earnings here.
According to InvestingPro, OKYO Pharma Ltd's Financial Health score is "weak performance".
Check out OKYO Pharma Ltd's recent earnings performance, and OKYO Pharma Ltd's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar